Nrf2 Deficit Prevents Pathologic Tau Seeding And Spreading In An Induced Tauopathy Mouse Model
Brain diseases like Alzheimer’s are often characterized by the accumulation and spread of abnormal proteins, one of which is called tau. Normally, tau helps stabilize brain cells, but in these diseases, it misfolds and forms harmful clumps that can then encourage other healthy tau proteins to misfold and spread throughout the brain, much like a chain reaction. This process, known as ‘tau seeding and spreading,’ is a major contributor to the progression of these debilitating conditions.
Scientists have been investigating various ways to halt this spread. One protein of particular interest is NRF2, which typically acts as a cellular protector, boosting the brain’s natural defenses against damage, including harmful oxidative stress. It was widely thought that enhancing NRF2 activity would be beneficial in neurodegenerative diseases.
However, a recent study has revealed a surprising finding. Researchers discovered that when NRF2 was deficient in a mouse model of brain disease characterized by tau accumulation, the spread of the harmful tau protein was significantly reduced. This unexpected outcome suggests that while NRF2 usually protects cells, its absence somehow creates an environment in the brain’s hippocampus—a region crucial for memory—that hinders the propagation of abnormal tau. This environment was marked by changes in the brain’s antioxidant defenses (mechanisms cells use to protect themselves from harmful molecules), alterations in supporting brain cells called astrocytes, and an imbalance in the different forms of tau protein.
This discovery challenges previous assumptions and highlights NRF2 as a critical player in the complex mechanisms that govern tau spread. It suggests that instead of simply boosting NRF2, a more nuanced approach might be needed, potentially targeting specific aspects of its function or the cellular environment it influences. This opens new avenues for developing therapies that could prevent the progression of tau-related brain diseases.
Source: link to paper